Schuurhuis J M, Spijkervet F K L, Vissink A, Stokman M A
Ned Tijdschr Tandheelkd. 2017 May;124(5):279-281. doi: 10.5177/ntvt.2017.05.17125.
In both patients who undergo radiotherapy because of a tumour in the head and neck region and patients who are treated with high doses of chemotherapy because of haematological disorders, prior to treatment an oral foci screening is carried out. The aim of this focus investigation is to identify oral abnormalities, the so-called oral foci. Such foci can lead to oral problems during or post-treatment. A careful oral foci screening, conforming to protocol, appears to be very relevant for patients who have to undergo head and neck radiotherapy. Particular attention must be devoted to the evaluation of the perodontium, because the chance of disorders affecting the bone-healing that appear post-radiotherapy in the head and neck region is increased in patients with periodontitis. In patients with a haematological disorder, asymptomatic, chronic foci do not require treatment prior to or during the oncological treatment because such oral foci do not increase an extra risk of infectious complications, despite what was hitherto believed.
对于因头颈部肿瘤接受放疗的患者以及因血液系统疾病接受高剂量化疗的患者,在治疗前均需进行口腔病灶筛查。此次病灶调查的目的是识别口腔异常情况,即所谓的口腔病灶。此类病灶可能在治疗期间或治疗后引发口腔问题。对于必须接受头颈部放疗的患者而言,按照规程进行仔细的口腔病灶筛查似乎极为重要。必须特别关注牙周组织的评估,因为牙周炎患者在头颈部放疗后出现影响骨愈合紊乱的几率会增加。对于患有血液系统疾病的患者,无症状的慢性病灶在肿瘤治疗前或治疗期间无需治疗,因为尽管此前人们一直认为此类口腔病灶会增加感染并发症的额外风险,但实际并非如此。